Limited impact of COVID‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis

BACKGROUND: The COVID‐19 pandemic reduced the number of skin cancer diagnoses, potentially causing a progression to unfavourable tumour stages. OBJECTIVES: To identify the impact of delayed diagnostics on primary invasive melanoma and cutaneous squamous cell carcinoma (cSCC) by comparing tumour (pT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangers, Tobias E., Wakkee, Marlies, Kramer‐Noels, Eline C., Nijsten, Tamar, Louwman, Marieke W.J., Jaspars, Elisabeth H., Hollestein, Loes M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111693/
https://www.ncbi.nlm.nih.gov/pubmed/35141890
http://dx.doi.org/10.1111/bjd.21050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111693/
https://www.ncbi.nlm.nih.gov/pubmed/35141890
http://dx.doi.org/10.1111/bjd.21050

Ejemplares similares